Aprea Therapeutics Inc
NASDAQ:APRE 3:50:49 PM EDT
Market Cap (Intraday) | 13.49M |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $3.76 |
50-Day MA | $4.20 |
200-Day MA | $4.07 |
Aprea Therapeutics Inc Stock, NASDAQ:APRE
3805 Old Easton Road, Doylestown, Pennsylvania 18902
United States of America
Phone: +1.617.463.9385
Number of Employees: 9
Description
Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of cancer therapeutics. It is involved in the development and commercialization of novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company was founded by Vladimir Bykov, Klas Gota Wiman, Staffan Stromblad, Natalia Issaeva, Galina Selivanova, and Wen Jie Bao in 2002 and is headquartered in Doylestown, PA.